Free Newsletter
Sanofi vet group plots $70M China expansion
Free newsletter via e-mail
Tools
Sanofi-Aventis animal health group Merial broke ground for a $70 million expansion of a poultry-vaccines plant in the Nanchang development zone in China. Release
Comments
Post new comment
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact
